NattoPharma ASA Exercise of options

Oslo, Norway (11 June 2020)

SPW, Inc. represented by Peter Stahl has exercised 25 000 options granted to him.

Following the exercise of the option SPW, Inc. will hold 25 000 shares in NattoPharma ASA.

Based on the power of attorney granted at the annual general meeting of NattoPharma ASA on May 29, 2019, the Board of Directors of NattoPharma has in board proceedings June 11, 2020 approved a share issue of 25 000 new shares, each with a face value of NOK 3 per share.

Price to be paid for each share is NOK 9,00 per share. The share issue is expected to be completed within end of June 2020.

As a result, the share capital will be increased by NOK 75 000. After completing the share issue the Company’s new share capital will be NOK 58 619 799 divided into 19 539 933 shares, each with a face value of NOK 3.

***

For more information, please contact:

Robert Schrama, CFO

E-mail: robert.schrama@nattopharma.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities